J. Lu’s research while affiliated with NCI-Frederick and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (6)


87 Critical difference in development of acquired resistance to MDM2 inhibitor SAR405838 in vitro and in vivo
  • Article

November 2014

·

21 Reads

European Journal of Cancer

G. Hoffman-Luca

·

·

J. Lu

·

[...]

·






Citations (1)


... Preclinical studies also suggest APG-1387 is a promising anticancer treatment. [162,163] ...

Reference:

Bivalent SMAC Mimetics for Treating Cancer by Antagonizing Inhibitor of Apoptosis Proteins
268 A potent and highly efficacious bivalent Smac Mimetic APG-1387 in Phase I clinical development
  • Citing Article
  • November 2014

European Journal of Cancer